You are on page 1of 19

FARMATRUST

SAVING LIVES | CREATING EFFICIENCIES

WHITEPAPER | v2.0
This information contained in this whitepaper is not intended for the residents of
the United States or Singapore. Before continuing, you agree that the information
in this whitepaper is solely for informational purposes and does not constitute
an offer to sell, or a solicitation of an offer to buy, any asset and/or security. You
agree and warrant that you are not a resident of the USA and/or Singapore and
do not and shall not rely or use the information herein to make any decisions in
respect of any instrument
Legal Disclaimer
This paper is for information purposes only and is not a statement of future intent.
FarmaTrust (the trading name of Chain PH Ltd.) makes no warranties or representations as to the successful
launch of the Token Distribution Event (TDE), or achievement of any other activities noted in this paper, and
disclaims any warranties implied by law or otherwise, to the extent permitted by law. No person is entitled to
rely on the contents of this paper or any inferences drawn from it, including in relation to any interactions with
FarmaTrust, the TDE or the technologies mentioned in this paper.
FarmaTrust disclaims all liability for any loss or damage of whatsoever kind (whether foreseeable or not) which
may arise from any person acting on any information and opinions relating to FarmaTrust, the FarmaTrust Zoi
platform or the TDE contained in this paper or any information which is made available in connection with any
further enquiries, notwithstanding any negligence, default or lack of care.
Whilst every effort is made to ensure that statements of facts made in this paper are accurate, all estimates,
projections, forecasts, prospects, expressions of opinion and other subjective judgments contained in this
paper are based on assumptions considered to be reasonable as of the date of the document in which they
are contained and must not be construed as a representation that the matters referred to therein will occur.
Any plans, projections or forecasts mentioned in this paper may not be achieved due to multiple risk factors
including without limitation defects in technology developments, legal or regulatory exposure, market volatility,
sector volatility, corporate actions, or the unavailability of complete and accurate information.
All TDE information contained in this document is intended to be indicative only and is not a statement of
FarmaTrust’s intentions. Any such information may be varied by FarmaTrust prior to the TDE. If so, any new
documentation will supersede this document and be available at https://www.FarmaTrust.io.

2 | Farmatrust whitepaper v2.0 14/03/2018


FarmaTrust is the trading name of Chain PH Ltd. registered in the UK which provides services to Chain PH Ltd. Unit 117 Orion Mall Palm Street Victoria Mahe Seychelles.
Summary
FarmaTrust is developing a fast, scalable, and secure blockchain solution that automates end-to-end tracking
of medicinal products throughout the pharmaceutical supply chain. By harnessing the growing efficiency
of big data, machine learning, blockchain technology and intelligent workflow processing, FarmaTrust both
accurately and securely records data relating to serialised packages as they pass through each point in the
supply chain lifecycle, in accordance with track and trace regulatory requirements.

“Fraudulent drugs harm or kill millions around the world and inflict serious damage on the brand names
and bottom lines of major pharmaceutical manufacturers.” (PWC Study) Pharmaceutical companies and
government programmes that provide subsidised medicines are also losing significant revenues and incurring
increased costs from counterfeit drugs, returns fraud and the regulatory burden from reporting and compliance.

The FarmaTrust Zoi system helps minimise the cost and resources required to comply with track and trace
regulations. In addition, the FarmaTrust system integrates with existing enterprise software solutions, reducing
the disruption to business operations and system changes in order to comply with track and trace reporting
requirements. Ultimately, the FarmaTrust solution provides a cost-effective and comprehensive option for
pharmaceutical companies, supply chain operators and retailers to verify and track genuine products across
the lifecycle, down to the individual packet level. FarmaTrust’s Zoi platform not only has pharmaceutical
companies as clients, but also includes Ministries of Health, governmental / regulatory bodies, NGOs and law
enforcements as its customers. The end users get a free-to-use app.

Overview
According to a recent PWC report (https://www.strategyand.pwc.com/reports/counterfeit-pharmaceuticals),
up to 30% of all drugs in circulation are fake, leading to up to a million deaths annually, including 450,000
preventable deaths from malaria alone. Some of these deaths can be attributed directly to the toxic
ingredients (such as rat poison, floor wax, industrial chemicals and the like) used to produce counterfeit
drugs. Many more are a result of substandard drugs being sold to unsuspecting consumers, with little to no
active ingredients present in drugs, which would otherwise have saved the consumers from preventable or
curable diseases.
Although less developed markets have long been their stronghold, pharmaceutical counterfeiters are now
using digital channels to penetrate developed countries, where traditional physical drug distribution networks
are well protected. Exacerbating this issue, the PMMI’s 2016 Brand Protection and Product Traceability report
found that “medicines bought over the internet that conceal their physical address are counterfeit in more than
half of cases. The reasons that proliferate online sales are mainly due to consumers not being able to afford to
visit a doctor or get medicine from a pharmacy.”

Despite the efforts of the pharmaceutical industry, major challenges remain. Such issues related to
pharmaceutical products include the differing legislations across jurisdictional borders, compliance thereof,
and the enforcement of these rules. In Europe, Directive 2011/62/EC, also known as the Falsified Medicines
Directive (FMD), is designed to fight against counterfeit medicines through serialisation and verification of
individual packages. This includes important information such as:

● Manufacturer product code


● Serial Number
● National reimbursement number, if present
● Batch Number
● Expiry Date

The US Drug Supply Chain Security Act (DSCSA) specifies more detailed information
related to each step of the supply chain including:
● Lot level traceability and verification for manufacturers, wholesalers,
re-packagers, and outlets, such as hospitals and retailers;
● Tracking changes of ownership across product batches; and
● Tracing serialised items with full product transaction history back to the original manufacturer.

3 | Farmatrust whitepaper v2.0 14/03/2018


While both US and European track and trace regulations require detailed and thorough end-to-end compliance
and traceability of drugs, different requirements and compliance enforcement policies across jurisdictions
around the world limit effective coordination and consistent application of these requirements in a globalised
cross-border supply chain.

Similarly, the plethora of legacy systems, technologies and methods used by each supply chain operator for
tracking and reporting packages have, to date, prevented the effective coordination and integration required
across the whole supply chain. 2D barcodes, QR codes, and a variety of different technical standards mean data
is usually held in technology silos, creating opportunities for malevolent actors to easily introduce counterfeit
products into the supply chain without being detected. Essentially, this fractured and broken process has meant
that the current pharmaceutical supply chain is left exposed to fraud and tampering, and/or restrictively siloed.

The FarmaTrust solution


The mission of FarmaTrust is to become the provenance system of choice for the pharmaceutical supply
chain, by providing an effective and global data verification and coordination layer which enables greater
transparency, efficiency, and immutability for the recording of all activities across the supply chain – from the
point of manufacture to the end consumer.

FarmaTrust has developed the blockchain-based Zoi Supply Chain Information Exchange platform to
securely verify and track the supply of genuine products across a diverse network of pharmaceutical brands,
manufacturers, distributors and supply chain operators, providing traceability and data services to governments,
law enforcement agencies, NGOs, retailers and end consumers.

FarmaTrust’s Zoi provides a secure, interoperable and immutable source of data which allows for tracking
of serialised products across an unbroken chain of custody throughout the supply chain. By integrating
blockchain technology with big data machine learning and intelligent business logic, the Zoi system helps
prevent fake and counterfeit medicines from easily entering the consumer market undetected. In addition,
FarmaTrust can provide value-added services such as predictive supplies and the most efficient routes to
market.

The Zoi platform is an innovative product tracking and reporting system designed to comply with industry track
and trace compliance and reporting requirements. This is achieved through a secure RESTful API interface
that integrates with existing supply chain management systems to securely share information about products
moving through the supply chain.

The platform solves current track and trace challenges by creating a unique digital token to reference every
Serialized Product Key from point of manufacture to point of sale or return. Zoi utilises blockchain technology
to capture and create an immutable record of product data across multiple differing supply chain systems,
ensuring transparency and compliance at each stage. The scalability of Zoi platform is designed to handle
millions of transactions using various techniques such as caching, data sharing, multi-processing, horizontal
scaling, high capacity servers and with utilisation of side-chains where applicable without compromising
performance and security. We will ensure that sensitive data will be encrypted and only decrypted by the
owner of the data via secret seed provided. We have a solution based on multi-sig transaction model. We
will use side-chain, permissioned blockchain which will provide full control of data to the stakeholders and
with dedicated servers hosted on highly secured network to communicate with the blockchain peer-to-peer
network.

FarmaTrust works with all parties in the supply chain to securely connect and streamline the sharing of data,
minimising the cost and risk associated with building new and complex systems in order to meet track and
trace regulatory requirements. The entirety of this system provides safe, secure, encrypted and immutable
data for all parties in the supply chain (from pharmaceutical companies, to manufacturers, logistics and supply,
governments, regulators, law enforcement) and most importantly, the end consumers.

4 | Farmatrust whitepaper v2.0 14/03/2018


FarmaTrust Product Features and Benefits
Supply Chain Data Automation
FarmaTrust has developed a neutral, inter-operable, and secure data exchange system that is scalable, flexible
and modular. The technical architecture uses RESTful API calls to coordinate data communication across
existing Supply Chain Management Systems (SCMS) and the Zoi information exchange network. This enables
both synchronous and asynchronous data connectivity across different organisations and handles the complex
task of coordinating systems in the pharmaceutical supply chain, removing the need for system harmonisation.

The smart contract ability of the blockchain that FarmaTrust is currently using allows the automating of some
pharmaceutical process capabilities and thereby gives our customers greater efficiencies. FarmaTrust has
the ability to automate payment processes, regulatory reportings, as well as audit trail requirements within
and between companies and as imposed by law. Such services will be developed on an on-going basis and
through customisation.

Smart Contracts and Intelligent Processing


Leveraging the capabilities of the Ethereum blockchain network, FarmaTrust partners with pharmaceutical
companies, government agencies and law enforcement to develop robust and intelligent data processes that
meet the track and trace compliance requirements. These include:
● Verifying the traceability of individual product packets, as required by track and trace regulation;
● Tracking a product’s journey through the supply chain;
● Real time tracking of product ownership and chain of custody;
● Data assurance and verification across the supply chain;
● Rules-based digital workflow processing;
● Inventory monitoring and surveillance; and
● Product authentication.

Data Security and Confidentiality


Communicating and sharing supply chain information may contain commercially sensitive or confidential
product information. FarmaTrust encrypts all datasets sent across the network. In addition, zero-knowledge
proof mechanisms ensure confidential and commercial data can be verified across different entities and regions
without exposing the information.

Packet Level Tracking and Traceability


Meeting track and trace regulatory requirements is difficult in a globalised supply chain. The DSCSA enacted in
the US requires more thorough traceability of prescription drugs within the supply chain compared to the FMD
within the European Union. The FarmaTrust Compliant Product (CP) tracking token is specifically designed to
digitally track genuine products that have been packed with unique Serialized Product Keys. This provides
packet level tracking and traceability of genuine products through its supply chain lifecycle.

Artificial Intelligence
Using blockchain as a base, and providing the value-added services listed above, we anticipate the expansion
of our services into machine learning. Currently, FarmaTrust plans to provide services which will allow
pharmaceutical companies to have predictive supply level information thereby reducing waste through expired
or non-use in a particular territory, improving ‘just in time’ supplier methodologies, and mitigating price spikes.
We also anticipate using AI to find the most efficient routes to market.

5 | Farmatrust whitepaper v2.0 14/03/2018


Advantages of the FarmaTrust System
Pharmaceutical companies
● Cost effective approach to meet track and trace regulatory compliance.
● Lightweight API driven system that is simple to integrate into supply chains.
● Minimal impact or disruption to existing systems.
● Low maintenance and overhead costs required to scale the system.
● Provides data transparency across the supply chain.
● Zero-knowledge proofs mean data can be kept confidential
and different pricing regimes for different customers.
● Machine learning services in respect to efficient routes to market.
● Predictive supply services in respect to providing information
on which medicines to supply where, when and the required quantities.

Supply chain companies


● Quick and cost effective to implement.
● Minimal impact and disruption to systems and processes.
● Easily integrates with existing supply chain management systems.
● Scalable, flexible, and robust enough to handle complex supply chain workflows.
● Zero-knowledge proofs mean data can be kept confidential.

Regulators and law enforcement


● Convenient access to real time information about medicinal products in the supply chain.
● A quick and easy method to verify status of genuine pharmaceutical products.
● Streamlined digital workflow and immutable record of data history minimises risk of manual errors.
● Instant access to accurate and complete product history.

Many countries now have regulators which monitor the pharmaceutical industry. This includes ensuring
pharmaceutical companies meeting minimum standards as well as having stringent reporting requirements.
FarmaTrust provides Regulators a data dashboard with an overview of the operations of the pharmaceutical
companies, their drugs, and activities in the territories that they manage and further ensure that they are
compliant with such regulations.

Governments / Ministries of Health


● Provides holistic view of medicines within the territory.
● Accurate and easy access to where state subsidies are being spent.
● Allows for financial and/or budget forecasting.
● Allows accountability of governmental bodies, spending and waste.
● Provides significant transparency in respect to State finances in healthcare.

In many countries, drugs are subsidised by the the government through tax payers. This national subsidised
system requires that public finances are auditable and spend efficiently. FarmaTrust gives governmental
organisations complete visibility across their territories, thereby allowing for future planning, budgeting and
use of funds, as well as waste, through expired drugs or “leakage”.

Retailers and consumers


● Confidence in the genuine source of pharmaceuticals.
● Increase confidence in purchasing online medicines.
● Reduced risk of purchasing fake or counterfeit products.
● Ability to quickly verify genuine products.

6 | Farmatrust whitepaper v2.0 14/03/2018


FarmaTrust Token Model
FTT Tokens
FarmaTrust will issue FTT tokens (an ERC20 standard token). The FTT token is the publicly tradable digital
asset that allows all users to access and participate in the Zoi ecosystem.

ZOI Tokens
● FTT token holders can stake their FTT tokens to receive ZOI tokens,
utility tokens used to fuel transactions and payments on the Zoi platform.
● 500 ZOI tokens are generated every 7 days when 100 FTT tokens are staked.
● ZOI tokens allow account holders, pharmaceutical companies,
supply chain companies, government, NGOs and law enforcement entities,
and end users to access information of products generated on the Zoi platform.
● ZOI tokens are only available to use on the Zoi platform,
and can be bought and sold on the FarmaTrust Zoi Exchange.
● ZOI tokens are burnt when used on the platform.

Compliance Tracking Token


To meet track and trace regulatory requirements, pharmaceutical companies can stake 100 FTT tokens to
generate a batch*** of Compliance Tracking tokens. Pharmaceutical companies can stake 100 FTT tokens in
Compliance Tracking Token Smart Bond. Smart Bond is a smart contract that binds the FTT tokens to a new
batch of Serialized Product Keys generated by a package manufacturer to meet track and trace compliance
requirements. Compliance Tracking token characteristics listed below:

● Each Compliance Tracking token digitally tracks an individual product packet that has been
assigned a unique Serialized Product Key through the supply chain and product lifecycle
● Compliance Tracking tokens are burnt when the packets are sold, or have been returned and destroyed
● Compliance Tracking Token data is archived on the system

Once all Compliance Tracking tokens from one batch are burnt, the Compliance Tracking Token Smart Bond
releases the 100 FTT tokens originally staked, allowing the tokens to be re-used to track a new batch of packets.

NOTE: A Compliance Tracking token is not a cryptocurrency, but a digital reference of a Serialized Product Key
on its own blockchain.

If pharmaceutical companies cannot acquire a sufficient number of FTT tokens (i.e. 100 FTT) to stake a batch
of Compliance Tracking tokens, ZOI tokens can be purchased and burnt instead, at a 1:1 ratio. In this case,
pharmaceutical companies must obtain sufficient ZOI tokens to cover a full batch.

Example: if a product batch produces 100,000 Serialized Product Keys, then 100,000 ZOI tokens must be
burnt to produce 100,000 Compliance Tracking tracking tokens.

***Batch sizes may vary across manufacturer and product lines

7 | Farmatrust whitepaper v2.0 14/03/2018


How the FarmaTrust Token model works
How the FarmaTrust Token model works

FTT token holders create an account on the Zoi platform

Token holders load FTT tokens into their Staking wallet on Zoi platform

Staking wallets earn 500 ZOI tokens each 7 days for every 100 FTT tokens staked

Pharmaceutical companies acquire FTT or ZOI tokens from Zoi Exchange

Pharmaceutical companies stake FTT tokens to digitally pair batches of Serialized


Product Keys that meet track and trace regulation

Each unique Serialized Product Key is tokenized with one Compliance Tracking token

Compliance Tracking tokens track product compliance across the supply chain and are
burnt when packets are sold or returned

Government departments, customs and law enforcement agencies use Compliance


Tracking tokens to track genuine products in real time

ZOI tokens are used to access and pay for data requests on the Zoi platform including
reports, product audits, packet history, notifications and alerts

Consumers, hospitals, NGOs and retailers can scan products and verify that a packet is
genuine using the Serialized Product Key

8 FarmaTrust
| Farmatrust whitepaper
whitepaperv2.0v2.0
14/03/2018
14/03/2018
FarmaTrust Token Ecosystem
FarmaTrust Token Ecosystem
FarmaTrustFarmaTrust
Token Ecosystem
Token Ecosystem

FarmaTrust Token Ecosystem

Figure 1: FarmaTrust supply chain data interaction and verification process


gure 1, FarmaTrust’s Zoi Exchange will allow pharmaceuticals and participants to buy ZOI tokens from the exchange. Once
tered, users will be able to purchase FTT tokens and store them in their FTT wallet. With business rules embedded in the
ng Smart Contract, they can stake ZOI tokens and lock them in their Zoi wallet. This allows them to access our supply chain
Figure 1: Figure 1: supply
FarmaTrust FarmaTrust supply chain data interaction and verification process
l to reap theIn benefits
Figure 1,
of the1:Zoi
Figure
FarmaTrust’s
platform.
FarmaTrust
Figure
Zoi Exchange 1:chain
Initially,
supply
FarmaTrust data the
chain
will allow
interaction
Compliance
supply
data interaction
pharmaceuticals chainand
and data
verification
Tracking and tokens
interaction
participants
process
verification
to buy ZOI
will
and be onfrom
process Ethereum
verification
tokens
blockchain,
process
the exchange. Once
but the
ework will In
enable
In Figure Figure
1, 1,
FarmaTrust’s
In FarmaTrust’s
interoperability
Figure Zoi
1, with
FarmaTrust’s
Exchange Zoiother
will Exchange
Zoi
allowblockchains
Exchange will
pharmaceuticals
will allow
allow in pharmaceuticals
the near
pharmaceuticals
and future.
participants to
andbuyand
As participants
our
participants
registered, users will be able to purchase FTT tokens and store them in their FTT wallet. With business rules embedded in theZOI tokensbusiness
tofrom
buy the
ZOIto
modelbuy
exchange.
tokens ZOI
is
from tokens
primarily
Once
the from
exchange.a B2B the model, it
Once
losed loop exchange.
pharmaceutical
registered,
Stakingusers will Once
registered,
Smart be able
Contract, registered,
supply
users
to they
purchase
Figure chain
will1:be
can users
network.
able
FTT
FarmaTrust
stake toZOIwill
tokens
purchasebe
and able
Each
store
supply
tokens FTT to
tokens
them
andchainlock purchase
networkindata
and
themtheir will
store
in FTT FTT
be
them tokens
Zoicustomised
wallet.
interaction
their in their
With and
andFTT
wallet. business store
wallet.
verification
This allows rulesthem
according
With
them toin
embedded totheir
business
process the
access in FTT
rulesunique
the
our wallet.
embedded
supply inWith
business
chain the needs of
Staking Smart
business
portal toInContract,
Staking
reaprules
the they
Smart can
embedded
1, benefits Contract,
stake
of ZOI
Zoiin
the Zoithey
tokens
the can stake
Staking
platform. and lock
ZOI
Smartthem
Initially,tokens in and
theirlock
theContract,
ComplianceZoi
andwallet.
them
they in This
their
can
Tracking allows
Zoi
stake
tokens wallet.
them
ZOI
will beThis
toonaccess
tokensallows
Ethereumandour
themsupply
lockto access
chain
Onceour
them
blockchain, supply
in their
but the Zoi chain
takeholders involved,
portal framework
to reap registered,
such
Figure
theportal
benefits to
as
reap
Manufacturer,
FarmaTrust’s
of the
the Zoi
Exchange Supply
will allow Chain Operator,
pharmaceuticals Logistics
participants to Provider,
buy ZOI tokens and
from Retailer.
the exchange.
will enable
users bebenefits
platform.
interoperability
will able ofwith
the
Initially,
to purchase Zoi
other
FTTplatform.
the Compliance
blockchains
tokens andInitially,
in Tracking
store the near
the
them Compliance
tokens
future.
in their will
Tracking
be With
As our
FTT wallet. on tokens
Ethereum
business
business will
modelblockchain,
be on
rules is Ethereum
butinathe
primarily
embedded blockchain,
B2B model,but
the it the
wallet.
framework
is a closed
This
willStaking
enable
framework
loopSmart
allows willthem
interoperability
enable
pharmaceutical
Contract, they
to
with access
interoperability
other
supply
can chain
stake
our
blockchains supply
with
ZOInetwork.
tokens other
in Each
and the chain
blockchains
near
lock
portal
future.
network
them in As
will
in their
to
the
be
Zoiourreap
nearbusiness
customised
wallet.
the model
future. benefits
As our
according
This allows
ofaccess
isbusiness
them primarily
toto
the
the
Zoi
model
aunique
B2B platform.
ismodel,
our supplyprimarily
business
Initially,
it aneeds
chain B2B model,
of it
thestakeholders
is a closed
the Compliance
loop pharmaceutical
is atoclosed
portal reap Tracking
loop
the supply
benefits
involved, suchof tokens
pharmaceutical
chain
as will
Zoinetwork.
theManufacturer, be Each
supply
platform. on
chain Ethereum
network
network.
Initially,
Supply the willblockchain,
Each
be customised
Compliance
Chain Operator,network
Tracking but
will
tokens
Logistics the
according framework
beProvider,
customised
will be to the
onand according
unique
Ethereum will
Retailer. enable
business butinteroperability
to the needs
blockchain, unique
theofbusiness needs of
with other
the stakeholders framework
the blockchains
involved, willsuch
enable
stakeholders in the near
asinteroperability
involved,
Manufacturer, suchwithfuture.
as
Supply As our
other Chain
blockchains
Manufacturer, business
in theLogistics
Operator,
Supply Chain model
near future. Asis
Operator, our
Provider, primarily
business
Logistics
and Retailer. a B2B
model
Provider, model,
is primarily
and a B2B
Retailer. it ismodel,
a closed
it loop
is a closed loop pharmaceutical supply chain network. Each network will be customised according to the unique business needs of
pharmaceutical supply chain network. Each network will be customised
the stakeholders involved, such as Manufacturer, Supply Chain Operator, Logistics Provider, and Retailer. according to the unique business needs
of the stakeholders involved, such as Manufacturer, Supply Chain Operator, Logistics Provider, and Retailer.

Figure 2: 2:
Figure FarmaTrust
FarmaTrust Zoi
Zoi platform token
platform token functionality
functionality
Figure 2Figure
explains how new
2 explains Figure
how 2: FarmaTrust
customer Figure
or existing
new customer 2: Zoi
FarmaTrust
token
or existing token platform
holders
holders can Zoi
token platform
participate
can participate functionality
in in
thethe token ecosystem.
functionality
FarmaTrust
FarmaTrust ecosystem.
Figure 2:how FarmaTrust
Figure 2 explainsFigure new
2 explains
Zoi
customer
how
platform
or new
existing
customer
token
token orholders
functionality
existing
cantoken
participate
holdersincan
the participate
FarmaTrustinecosystem.
the FarmaTrust ecosystem.
Figure 2 explains how new customer or existing token holders can participate in the FarmaTrust ecosystem.

FarmaTrust
FarmaTrust whitepaper
whitepaper v2.0v2.0 14/03/2018
14/03/2018
9 | Farmatrust whitepaper v2.0 14/03/2018
FarmaTrust Figure 2: FarmaTrust Zoi platform token functionality
whitepaper
FarmaTrust v2.0
whitepaper v2.0 14/03/2018 14/03/2018
e 2 explains how new customer or existing token holders can participate in the FarmaTrust ecosystem.
ABC Pharmaceutical Co. produces generic medicines for the North American, European and Asian
markets, and is working with ACME Medical Products to implement a new Serialized Product Labelling
system to help them meet the track and trace regulation compliance requirements from the US and
Europe. ABC Pharmaceutical Co. has recently partnered with FarmaTrust to trial the Zoi Supply Chain
Sample
Information Exchange use case scenario - ABC Pharmaceutical Co.
platform.
ABC Pharmaceutical Co. (not a real company) is a pharmaceutical company with 3 product brands, and 20
FarmaTrust works
product lineswith
that both ABC Pharmaceutical
are produced Co. andACME
by a contract manufacturer, ACME Medical
Medical Products
Products Ltd
Ltd (also nottoa integrate
real its
API clients and agents
company) onto in
in 4 factories both company’s internal Supply Chain Management (SCM) systems. They
Ireland.
also work with the downstream supply chain operators, logistics partners, hospitals and retail chains to
ABC Pharmaceutical Co. produces generic medicines for the North American, European and Asian markets, and is
integrate working
the FarmaTrust API clients
with ACME Medical Productsinto their systems.
to implement a new Serialized Product Labelling system to help them meet
the track and trace regulation compliance requirements from the US and Europe. ABC Pharmaceutical Co. has
ABC Pharmaceutical Co.
recently partnered withruns a trialtoon
FarmaTrust trial2the
product lines
Zoi Supply inInformation
Chain one of their factories:
Exchange platform.one product line
producesFarmaTrust
20,000 packets of generic brand aspirin tablets a week in 4 batches of 5,000 packets; the
works with both ABC Pharmaceutical Co. and ACME Medical Products Ltd to integrate its API
second line produces
clients 10,000
and agents bottles
onto both of generic
company’s brandChain
internal Supply cough syrup a (SCM)
Management weeksystems.
in 5 batches ofwork
They also 2,000.
with the downstream supply chain operators, logistics partners, hospitals and retail chains to integrate the
For the FarmaTrust
trial, API clients into their Co.
ABC Pharmaceutical systems.
buys 100,000 FTT tokens from the Zoi platform and stores them
the company FTT wallet. 100
ABC Pharmaceutical FTTatokens
Co. runs trial on 2are withdrawn
product from
lines in one the factories:
of their FTT walletone for each
product linebatch produced a
produces
deposited20,000
into packets
the Compliance Tracking
of generic brand Token
aspirin tablets Smart
a week Bond. of
in 4 batches Each
5,000week,
packets;athe
total of 900
second FTT tokens are
line produces
bonded. 10,000 bottles of generic brand cough syrup a week in 5 batches of 2,000.

For the trial, ABC Pharmaceutical Co. buys 100,000 FTT tokens from the Zoi platform and stores them in the
Each batch of aspirin
company packets
FTT wallet. 100 FTTrequires
tokens are5,000 unique
withdrawn Compliance
from the FTT wallet forTracking
each batch tokens, corresponding
produced and deposited to ea
individualinto
serialized packet
the Compliance of aspirin,
Tracking while
Token Smart each
Bond. Eachbatch
week,of cough
a total syrup
of 900 requires
FTT tokens 2,000 unique
are bonded.
Compliance Tracking tokens, which correspond to each serialized bottle.
Each batch of aspirin packets requires 5,000 unique Compliance Tracking tokens, corresponding to each
individual serialized packet of aspirin, while each batch of cough syrup requires 2,000 unique Compliance
As the aspirin packets
Tracking and cough
tokens, which medicine
correspond bottlesbottle.
to each serialized move through the supply chain, the FarmaTrust API
registers, validates and confirms the details of each exchange, tracking and matching the data from the
As the aspirin packets and cough medicine bottles move through the supply chain, the FarmaTrust API registers,
various SCM systems as the products move from one entity to the next, and are subdivided into lots, a
validates and confirms the details of each exchange, tracking and matching the data from the various SCM
consignments,
systemsthat
as theultimately get from
products move delivered to to
one entity thethehospitals and
next, and are retailers.
subdivided into lots, and consignments,
that ultimately get delivered to the hospitals and retailers.
Compliance Tracking tokens are updated on the blockchain with a reference to the relevant event detai
Compliance Tracking tokens are updated on the blockchain with a reference to the relevant event details
including including
Batch, Batch,
Lot and Consignment
Lot and Consignment information. When
information. When packets
packets are soldare sold
by the by or
retailer the retailerbyorthe
dispensed dispensed
by the hospital,
hospital, or returned
or returned for for disposal,
disposal, the corresponding
the corresponding Compliance
Compliance Tracking Tracking
tokens are burnt. tokens are burnt.

The initial bond is released once all Compliance Tracking tokens belonging to a batch are burnt.
The initial bond is released once all Compliance Tracking tokens belonging to a batch are burnt.

Figure 3:
FarmaTrust supply chain
ecosystem engagement

Figure
10 | Farmatrust whitepaper v2.03: FarmaTrust supply chain ecosystem
engagement 14/03/2018
Token Distribution Event details
Token Name: FarmaTrust Token
Token Symbol: FTT
Type: ERC20
Utility: FTT
Total Supply: 1,000,000,000 (1 Billion)
Token Sale: 600,000,000 (600 Million)
Listing Price: USD $0.05
TDE Soft Cap: USD $7,000,000
Sale Hard Cap: USD $20,250,000

Allocation*:
200,000,000 tokens - Tranche 1 (Private Sale - 40% discount)
*Any unsold FTT tokens from the TDE will be added to the Partnership pool or other pools as required by
150,000,000 tokens - Tranche 2 (Institutional Investors - 30% discount)
the management at their discretion.
100,000,000 tokens - Tranche 3 (Pre-Sale - 20% discount)
100,000,000 tokens - Tranche
Partnership pool - 100 million 4 (Public
FTT tokens will Sale - 0% discount)
be reserved as an incentive pool to attract partner supply
50,000,000 tokens - Bounty and referral program
chain
*Any companies
unsold FTT tokensand
fromgovernment regulators
the TDE will be added to to
theparticipate
Partnership on the
pool or platform.
other pools as required by
the management at their discretion.
Team pool - 100 million FTT tokens will be reserved for the team, which will be vested. The vesting
Partnership pool - 100 million FTT tokens will be reserved as an incentive pool to attract partner supply
structure will be:
chain*Any unsold
companies FTT
and tokens from
government the TDE
regulators will be added
to participate to the Partnership pool or other
on the platform. pools as required by the
management at FTT
50 million theirtokens
discretion.
will be released after 6 months.
Team pool - 100 million FTT tokens will be reserved for the team, which will be vested. The vesting
The remaining 50 million released at the end of 12 months.
Partnership
structure will be:pool - 100 million FTT tokens will be reserved as an incentive pool to attract partner supply chain
companies andtokens
50 million FTT government regulators
will be released after to participate on the platform.
6 months.
Advisor pool - 100
The remaining 50 million
million released at thewill
FTT tokens endbe
of reserved
12 months.fo Advisors. Advisor pool tokens have the same
Team pool - 100 million FTT tokens will be reserved for the team, which will be vested. The vesting structure will be:
vesting structure as the Team pool.
- 50 million FTT tokens will be released after 6 months.
Advisor pool remaining
- The - 100 million50
pool - The million
FTT tokensreleased at theFTT
will be reserved foend of 12Advisor
Advisors. months.pool tokens have the same
Operations remaining 100 million tokens will be reserved for covering operational costs.
vesting structure as the Team pool.
Advisor pool - 100 million FTT tokens will be reserved fo Advisors. Advisor pool tokens have the same vesting
Operations pool - The remaining 100 million FTT tokens will be reserved for covering operational costs.
structure as the Team pool.

Operations pool - The remaining 100 million FTT tokens will be reserved for covering operational costs.

Figure 4:
FarmaTrust Token Allocation
Figure 4: FarmaTrust Token Allocation

Figure 4: FarmaTrust Token Allocation

11 | Farmatrust whitepaper v2.0 14/03/2018


Technology and ecosystem development - 40% of the funds raised will be used to develop the full
stack Zoi exchange network, platform and ecosystem.
Distribution of Proceeds
System security, auditing and compliance reporting - 20% of the funds raised will be used to secure
the communication and endpoint systems that interact with the Zoi platform, as well as develop the
Technology
Technology
andand
necessary reporting
ecosystem
and ecosystemcompliance
development
developmentbackend
- 40% of the
infrastructure,
- 40% of
funds
to will
the funds raised enable
raiseddevelop
will
neartoreal
be used
besystem
used
time the
to develop the full stack Zoi
full reporting,
stack
exchange network,
Zoi exchange
platform
network,reporting.
and ecosystem.
platform and ecosystem.
auditing and compliance
System
System
Marketing security,
security,
and auditing
businessauditing
and and compliance
compliance
development reporting reporting
- 20% of -funds
20% of - 20%
the funds
raised will ofwill
raised
be used the
tobe funds raised
securewill
usedmarketing
drive to be used to secure the
initiatives
to raise the profile of FarmaTrust and attract participants across the global pharmaceutical and logistics the necessary
communication
the communication and and endpoint
endpoint systems
systems that
that interact interact
with the Zoi with the
platform, Zoi
as platform,
well as develop as well
the as develop
reporting
necessary andand
reporting
supply chain.
compliance
compliance backend infrastructure,
backend infrastructure, to enable
to enable near realnear real time
time system system reporting, auditing and
reporting,
compliance
auditing reporting.
and compliance reporting.
Legal, accounting and administration - 20% of funds will be allocated to cover operational, legal,
Marketing and business development - 20% of funds raised will be used to drive marketing initiatives
Marketing
accounting and and business
overhead costsdevelopment - 20% of funds raised will be used to drive marketing initiatives to raise
to raise the profile of FarmaTrust andassociated with complying
attract participants with
across the professional.
global pharmaceutical and logistics
the profile of FarmaTrust and attract participants across the global pharmaceutical and logistics supply chain.
supply chain.

Legal,
Legal, accounting
accounting and administration
and administration - 20%
- 20% of funds will of
be funds willtobe
allocated allocated
cover to cover
operational, legal, operational, legal, accounting
and overhead
accounting costs
and overhead associated
costs associatedwith
with complying with
complying with professional.
professional.

Figure 5:
Token Distribution Event Proceeds

Figure 5: Token Distribution Event Proceeds


Figure 5: Token Distribution Event Proceeds

FarmaTrust
FarmaTrustwhitepaper
whitepaperv2.0
v2.0 14/03/2018
14/03/2018

12 | Farmatrust whitepaper v2.0 14/03/2018


Business Development Strategy and Direction
FarmaTrust has already developed a functional Alpha product that is undergoing robust private testing.
FarmaTrust is actively signing agreements and formal partnerships with international pharmaceutical companies,
government and law enforcement organisations.
The primary focus is to develop a strong, robust and complete system that will provide a compelling compliance
offering for the pharmaceutical industry and supply chain operators.

Strategy includes:
1. Exploring partnership opportunities in the US and EU
2. Expanding service offerings to developing markets in Asia and Africa
3. Providing data products and services for government and law enforcement
4. Develop and deliver mobile applications and responsive client interfaces
5. Collaborate with cross-border and health industry bodies to expand service offering

13 | Farmatrust whitepaper v2.0 14/03/2018


FarmaTrust Team
FarmaTrust Team

FarmaTrust Team
Lord Anthony
Chairman St John of Bletso
Chairman
Lord Anthony St John of Bletso is a Crossbench/Independent Member of
FarmaTrust Team the House of Lords, he was brought up in South Africa, where he qualified
Lord
Chairman
as Anthony
a solicitor. St JohnhisofMasters
After completing Bletso is aat Crossbench/Independent
in Law London University, he Member of the House of
Lords,
Lord
worked ashe
Anthony was brought
Stcounsel
legal John of for
Bletso up a in
isand
Shell South
an oilAfrica,
Crossbench/Independent
then where
Member
analyst/specialist he qualified
offor
sales as a solicitor. After completing
hisHouse
the Masters
several ininheLaw
of Lords,
institutions was
the atincluding
London
brought
City, up in University,
South
Merrill heheon
Africa,focusing
Lynch, where worked
qualified
Sub- as legal counsel for Shell and then
ana solicitor.
oil African
Chairman
as
Saharan analyst/specialist
After
andcompleting sales
his He
the Far East. Masters for several
in Law
is currently institutions
at London
Chairman ofUniversity,
Strand he in the City, including Merrill Lynch,
focusing
worked
Lord
Hanson as
Anthony
and on
legal Sub-Saharan
Stcounsel
John
Integrated for Shellisand
ofDiagnostic
Bletso African
then anplc
aHoldings and
oiland theonFarthe East.
analyst/specialist
Crossbench/Independent
serves Member ofHe is currently Chairman of Strand
salesoffor
board
Hanson
several
the House ofand
public andIntegrated
institutions
Lords,inhe
the
was
private City,
brought
companiesDiagnostic
including
up Merrill
in
and South Holdings
Lynch,
Africa,
has recently where plc
focusing
become on
he and serves on the board of several public
Sub-
a qualified
member

Lord Anthony St John of


and
Saharan
as
of private
African
a solicitor.
the House After
of companies
and the
AdFar
completing
Lords HocEast. and
his He
Masters
Select has
is currentlyrecently
in Law
Committee Chairman become
atArtificial
on London Strand ahemember of the House of Lords Ad
ofIntelligence.
University,

Bletso
Hoc
Hanson
worked
His Select
and
as legal
specialist Committee
Integrated
counsel
interests Shellon
Diagnostic
forcyber
are and Artificial
Holdings anplc
thenfinancial
security, Intelligence.
oiland serves onandthe
analyst/specialist
services His
sales specialist
lifeboard of
for interests are cyber security,
financial
several
sciences.publicservices
institutions in the and
and private City, life sciences.
companies
includingand has recently
Merrill become on
Lynch, focusing a member
Sub-
of the House
Saharan of Lords
African AdFar
and the Hoc Select
East. He Committee
is currently on ArtificialofIntelligence.
Chairman Strand
Lord Anthony St John of
His specialist
Hanson interests are
and Integrated cyber security,
Diagnostic Holdingsfinancial
plc andservices andthe
serves on lifeboard of
Bletso CEO and Founder
sciences.
several public and private companies and has recently become a member
Raja Sharif is the Founder and CEO of FarmaTrust. He is driving the
of the House of Lords Ad Hoc Select Committee on Artificial Intelligence.
Lord Anthony St John of company’s vision and mission of protecting the vulnerable by eliminating
His specialist interests are cyber security, financial services and life
Bletso CEO
deadlyand Foundermedications on a global scale and providing data
counterfeit
Raja
sciences.
Raja
services
Sharif
Sharif is the
to the Founder and CEO
pharmaceutical of FarmaTrust.
industry. He is driving
He is a corporate the
and commercial
CEO and
company’s
Barrister Founder
by vision and mission
background, ofworked
having protecting the vulnerable
as General Counselbyand
eliminating
company
CEO and
deadly
secretary Foundermedications
counterfeit
managing legal affairs,onrisk
a global scalecorporate
and good and providing data He
governance.
Raja
services
Raja
has Sharif
to the
Sharif
sat on the
is the is the
Founder
Boards Founder
pharmaceutical industry.
and of
of most CEO and
He isCEO
theofcompanies
FarmaTrust. ofis driving
a corporate
Hewas
and FarmaTrust.
involved He
and commercial
usuallythe is driving the company’s vision
and mission
Barrister
company’s by vision
in M&A activity of
background,
as and protecting
as having
well mission worked
listingofRaja the
hasas
protecting vulnerable
General aCounsel
the vulnerable
managed by
byand
number eliminating
company
eliminating
of technology deadly counterfeit medications
on
deadlya
secretary
and media global
managing
counterfeit scale
projectsmedicationsand
legal affairs,
worldwide forproviding
onrisk andofgood
a global
some scale
the data services
corporate
and
best governance.
providing
known to
data He
brands, the pharmaceutical industry. He is a
corporate
has sat
services on
includingto the and
Boards commercial
of most
the pharmaceutical
British of the
Telecom and Alindustry. Barrister
companies
Jazeera.He andby background,
was
Heisestablished usually
a corporateFarmaTrustinvolved
and commercial
after having worked as General Counsel
Raja Sharif
and
in M&A company
Barristeractivity
by as well
background,secretary
as listing
having Raja managing
workedhasasmanaged
researching and developing the blockchain service. General legal
a number
Counselaffairs,
of
and risk
technology
company and good corporate governance.
Hemedia
and hasmanaging
secretary sat onworldwide
projects theaffairs,
legal Boards
forrisk
someofofgood
and most
the best of thegovernance.
known
corporate companies
brands, He and was usually involved in M&A
activity
including
has as Boards
sat onBritish
the well as
Telecom listing
and
of most Al Raja
of Jazeera.
the has
He
companies managed
established a number
and was FarmaTrust
usually after of technology and media projects
involved
Raja Sharif
worldwide
researching
in M&A activity for
andas some
developing
well of blockchain
the
as listing the has
Raja best known
service.
managed brands,
a number including British Telecom and Al Jazeera.
of technology
Hemedia
and
COO
established FarmaTrust
projects worldwide for someafter
of theresearching
best known brands,and developing the blockchain service.
including
As COO ofBritish Telecom
FarmaTrust, and works
Peter Al Jazeera. He established
on planning, FarmaTrust
coordinating and after
Raja Sharif
researching
managing theand developing
company’s the blockchain
strategic businessservice.
operations. Before joining the
Board
COO of FarmaTrust, Peter has successfully created and grown
As COO of FarmaTrust,
businesses, Peter
realised value workstrade
through on planning,
sales andcoordinating andin a
been involved
managing the Buy
Management company’s
In (MBI)strategic business
of Guardian operations.
IT which Before
later resulted in joining
a full the
Peter
Board
market
COO Bryant
offlotation
FarmaTrust,
on thePeter hasStock
London successfully created
Exchange. He isand grown
familiar with
COO
businesses,
As ofrealised
COO of FarmaTrust,
obligations value
operating through
Peter workstrade
a company, salesduties
andcoordinating
on planning,
directors been
and involved
holds andin a
a number of
Management
managing the Buy
Chairman and In (MBI)strategic
company’s of Guardian
Non-executive IT which
business
directorships later resulted
ofoperations.
technology in joining
Before a full the
companies.
As COO
market
Board ofon the
offlotation
FarmaTrust,FarmaTrust,
London
Peter hasStock Peter
Exchange.
successfully works
He isand
created on
familiar
grown planning,
with coordinating and managing the
FarmaTrust whitepaper v2.0 company’s strategic business operations. Before
obligations ofrealised
businesses, operating a company,
value directors
through trade salesduties and involved
and been in a joining
holds a number of theBoard of FarmaTrust, Peter
14/03/2018
has successfully
Chairman
ManagementandBuy In (MBI)created
Non-executive and
directorships
of Guardian ofgrown
technology
IT which businesses,
companies.
later resulted in a full realised value through trade sales
and been
market flotationinvolved
on the Londonin Stock
a Management
Exchange. He is Buy
familiarIn (MBI) of Guardian IT which later resulted
with

FarmaTrust whitepaper v2.0 in a full ofmarket


obligations operatingflotation
a company,on the London
directors Stock
duties and holds Exchange.
a14/03/2018
number of He is familiar with obligations
of operating
Chairman a company,
and Non-executive directors
directorships dutiescompanies.
of technology and holds a number of Chairman and Non-
executive directorships of technology companies.
FarmaTrust whitepaper v2.0 14/03/2018

14 | Farmatrust whitepaper v2.0 14/03/2018


CTO
Shahnawaz is a senior technologist with over 21 years of IT experience in
managing,Aziz
Shahnawaz
CTO architecting, designing and developing software applications
Peter Bryant Shahnawaz is a senior technologist with over 21 years of IT experience in
CTO
across Financial Services, Investment Banking, Shipping & Logistics and
managing, architecting, designing and developing software applications
Government
across projects.
Financial Services, He Banking,
Investment has been involved
Shipping in blockchain
& Logistics and for a number of
Shahnawaz is a senior technologist with for over 21 years of IT experience in managing,
years.Shahnawaz
Government projects. He hashas beenainvolved
visionary ability to
in blockchain solve complex
a number of solutions using
architecting, designing and developing software
years.Shahnawaz has a visionary ability to solve complex solutions using
applications across Financial Services,
Blockchain,
Investment Social, Cloud,
Banking, Shipping Mobile,
& AI and Bigand
Logistics Data. Recently he projects. He has been
Government
Blockchain, Social, Cloud, Mobile, AI and Big Data. Recently he
CTO
involved
Shahnawaz
successfully
in
successfully
is a blockchain
senior
launched launched for
technologist
HD HD a bitcoin
with
bitcoin wallet
number of ofyears.Shahnawaz
wallet
overblockchain
and 21 years and
IT blockchain
experience
platform, in has a visionary ability to solve
platform,
complex
managing, solutions
architecting, using Blockchain, Social, Cloud, Mobile, AI and Big Data. Recently
showcased
showcased via designing
via nTrust.com. nTrust.com.
He alsoand developing
alsosoftware
He global
delivered bitcoin applications
delivered global bitcoin trading
trading
he successfully
across
platformFinancial
launched
Services,
earlier this year.HeInvestment
HD
also has aBanking,
bitcoin
number of
wallet
Shipping
patents&including
and blockchain
Logisticspatent
and platform, showcased via
Shahnawaz Aziz platform
nTrust.com.
Government
earlier
He
projects. alsothis year.He
delivered
HeMultiparty
has been involved
also
global has a number
bitcoin
in blockchain
of
trading
for aTransfer
patents
number of platform
of
including
earlier patent
this year.He also has
rights assigned: ``Secure loss resistant Storage and
Shahnawaz Aziz a number of patents including patent rights assigned:
rights assigned:
years.Shahnawaz
Cryptographic Keys has ``Secure
fora blockchain
visionary Multiparty
ability loss solutions
to solve complex resistant Storage and Transfer of loss resistant
using ``Secure Multiparty
Storage and Transfer of Cryptographic
Blockchain, Social, Cloud, Mobile, AI and Big Data. Recently he Keys for blockchain
Cryptographic Keys for blockchain
successfully launched HD bitcoin wallet and blockchain platform,
showcased
CFO via nTrust.com. He also delivered global bitcoin trading
platform
Alan is a earlier
career this year.He
‘C’ level also professional,
finance has a numberwith
of patents including patent
an entrepreneurial IT
Shahnawaz Aziz
rights
trackCFOassigned:
record from``Secure
start upMultiparty
to SME toloss
full resistant Storage and
listed experiences. HeTransfer of
has 25 plus
Cryptographic
years Keys for
of directorship blockchain
roles in corporate finance, general and financial
AlanAlanPalmer
is a career ‘C’ level finance professional, with an entrepreneurial IT
management and operations. Sub sector experiences include IT Services,
CFO track record
IT Software, from
and ‘Low’ start up[primarily
Technologies to SME to fullefficiency
in energy listed experiences.
‘green’ He has 25 plus
CFO
technologies].
years of Geographic regions
directorship of experience
roles includefinance,
in corporate UK, Europe,
general and financial
Alanisand
Alan
Africa aiscareer
a career
the USA. Alan‘C’
‘C’ level is a level
finance finance
professional,
Chartered professional,
with
Accountant anby with
entrepreneurial IT an
profession with an entrepreneurial IT track record
from
track
management
start
record up to
from start
and
SME operations.
up to SME to Sub sector experiences include IT Services,
to full listed experiences. He has 25 plus has 25 plus years of directorship
full listed experiences. He
honours business and finance degree.
Alan Palmer
roles
years in corporate
ITofSoftware,
directorship and finance,
‘Low’
roles in general
Technologies
corporate and
finance, general financial
[primarily management and operations.
in energy efficiency
and financial ‘green’ Sub sector
experiences include IT Services, IT Software,
management and operations. Sub sector experiences include IT Services, and ‘Low’ Technologies [primarily in energy
technologies]. Geographic regions of experience include UK, Europe,
efficiency ‘green’ technologies]. Geographic regions
IT Software, and ‘Low’ Technologies [primarily in energy efficiency ‘green’ of experience include UK, Europe,
Africa
Africa andand the
the USA.
USA. Alan
Alan is
is a aChartered
Chartered Accountant
technologies]. Geographic regions of experience include UK, Europe, Accountant by profession
by with
profession an
with an honours
business
honours
Africa
Head and
of theand
USA. finance
business
Implementation
degree.
Alan is aand finance
Chartered degree.
Accountant by profession with an
Alan Palmer
honours business
Steve comes from and financeengineering
a software degree. background. His expertise lies in
Alan Palmer
the installation of large scale systems from the point of analysis,
implementation and then testing. He has worked for some of the largest
brand names in the financial sector such as Investec, Royal Bank of
Scotland, Lloyds, UBS and Barclays, ensuring the integrity of data and
Steve
Head Mcavoy
of service
meeting Implementation
level agreements. He has also worked in the governmental
Head
and
Head
Steve comes
defense
of Implementation
of Implementation
from a software engineering background. His expertise lies in
sectors.
Steve comes
the installation of largefrom a software
scale systems engineering
from the background.
point of analysis, His expertise lies in
Steve comes
implementation andfrom a software
then testing. He has engineering
worked for somebackground.
of the largest His expertise lies in the installation
Steve Mcavoy the installation of large scale systems from the point of analysis,
of large scale systems from the point of analysis,
brand names in the financial sector such as Investec, Royal Bank of implementation and then testing. He has
implementation
worked for some ofand
thethen testing.
largest brand He has
names worked
in the for some
financial
Scotland, Lloyds, UBS and Barclays, ensuring the integrity of data and of the
sector largest
such as Investec, Royal
Bank of
brand Scotland,
names Lloyds, UBS
in the financial and
sector Barclays,
such ensuring
asgovernmental
Investec, the integrity of data and meeting
14/03/2018Royal Bank of
meeting service level agreements. He has also worked in the
FarmaTrust whitepaper v2.0
service level agreements.
and defense sectors. PAG He has also worked in the governmental and defense sectors.
Scotland, Lloyds, UBS and Barclays, ensuring the integrity of data and
E
meeting service level agreements. He has also worked in the governmental
Steve Mcavoy
and defense sectors.

FarmaTrust whitepaper v2.0 14/03/2018


Steve Mcavoy Eszter
Head Bohus
of Global BrandPAG
Marketing & Communications
Head
As Headof Global
of Global Brand Marketing
E& MarComms
Brand & Communications
of FarmaTrust, Eszter is planning,
coordinating and managing the company’s marketing communication
As Head
activities and of Global
consistent Brand
brand & MarComms
presence of FarmaTrust,
on all platforms. Eszter has Eszter is planning, coordinating
and managing
FarmaTrust whitepaper v2.0
worked the company’s
in a number of marketing marketing
roles, internationally, communication
which most recently activities and consistent
14/03/2018
brand
have presence
included Al Jazeeraon all Network.
Media platforms.
PAG Eszter
She has has
worked for worked
a number of in a number of marketing roles,
internationally,
international which
bodies and most recently
has organised
E a number ofhave
events included Al
with attendees Jazeera Media Network. She has
worked
from aroundfor
theaworld
number of and
Core skills international bodies and
professional experiences has
include butorganised a number of events with
attendees
are not limited from around
to managing thedepartments
diverse world Core skills
parallel on a and
numberprofessional
of experiences include but are
not limited
projects to managing
and multi-million diverse
dollar budgets departments
globally, parallel
with strong focus on on a number of projects and multi-
Eszter Bohus
million
brand dollar
identity budgets
development globally,
to meet with
corporate strong focus
development on brand identity development to meet
vision and
corporate
strategy. development
Eszter visionand
is a passionate activist and strategy.
advocate Eszter is a passionate activist and advocate for
for environmental
environmental
issues issues and
and wildlife protection, enjoyswildlife protection,
diving, kitesurfing enjoys
and beach diving, kitesurfing and beach tennis.
tennis.

Senior Software Developer & Product Development


15 | Farmatrust whitepaper v2.0 14/03/2018
Mike Barbarelli is a senior software developer for Farmatrust. He plays a
role in software requirements analysis, design, testing and deployment. He
issues and wildlife protection, enjoys diving, kitesurfing and beach tennis.
Eszter Bohus
strategy. Eszter is a passionate activist and advocate for environmental
issues and wildlife protection, enjoys diving, kitesurfing and beach tennis.

Mike Software
Senior Barbarelli
Developer & Product Development

Senior
Mike Software
Barbarelli Developer
is a senior & Product
software developer Development
for Farmatrust. He plays a
Senior Software
role in software Developer &analysis,
requirements Productdesign,
Development
testing and deployment. He
Mike Barbarelli is a senior software developer for Farmatrust. Hehas
plays a
Mike Barbarelli is a senior software developer for FarmaTrust. He plays a role in software
has over a decade of experience in full stack web development, been
role in software requirements analysis, design, testing
and isand deployment. He
requirements
involved analysis,
with blockchain design,
technology since 2016testing and
a certifieddeployment.
He has over a decade of
Ethereum
has over a decade of experience in full stack web development, has been
experience
developer. in full stack web development, has been involved with blockchain technology
involved with blockchain technology since 2016 and is a certified Ethereum
since 2016 and is a certified Ethereum developer.
developer.

Mike Barbarelli

Mike Barbarelli

Social Media Lead


Jenny is the social media lead for FarmaTrust. Before joining FarmaTrust,
Dr.has
she Jenny
Social Media Lee
Lead
previous experience in digital marketing and Financial Public
Social
Jenny is Media
the social
Relations. She holds Lead
media leadinfor
an MSc FarmaTrust.
Strategic Before
Marketing joining
from FarmaTrust,
Imperial College
she has and
London previous
prior experience in digital
to her Master’s degreemarketing and Financial
Jenny studied Public
Bachelor in
Jenny is
Relations.
Medicine, Shethe
holdssocial
Bachelor inan
Surgerymedia
MSc in lead
Strategic
and for from
Marketing
Bachelor FarmaTrust.
in Obstetrics Imperial Before joining FarmaTrust, she has
College
at the Royal
previous
London and experience
prior to her in
Master’s digital
degree marketing
Jenny studied and
Bachelor
College of Surgeons in Ireland, gaining an MB, BCh, BAO (NUI) and Financial
in Public Relations. She holds an
MSc inLRCP
Medicine,
historical Strategic
Bachelor
& SI.inJenny Marketing
Surgery
is aand from
Bachelor
native Imperial
in Obstetrics
Mandarin speaker College
at the
and her London
Royal
brings and prior to her Master’s
degree
College of Jenny
Surgeons
skills to FarmaTrust. studied
in Ireland, Bachelor
gaining an MB, in
BCh, Medicine,
BAO (NUI) and Bachelor in
Surgery and Bachelor in
Dr. Jenny Lee
Obstetrics
historical LRCP &atSI.the
JennyRoyal College
is a native Mandarin of Surgeons
speaker and bringsin
herIreland, gaining an MB, BCh, BAO
(NUI)
skills and historical LRCP & SI. Jenny is a native Mandarin speaker and brings her
to FarmaTrust.

Dr. Jenny Lee skills to FarmaTrust.


FarmaTrust whitepaper v2.0 14/03/2018

FarmaTrust whitepaper v2.0 14/03/2018

Jeffrey Middelbos
Community Manager
Community
Jeffrey MiddelbosManager
is the community manager for FarmaTrust. He manages
bitcointalk, Reddit and Telegram channels as well as ICO communications.
Jeffrey
By Middelbos
background isITthe
Jeffrey is an community
engineer manager
and works for for FarmaTrust.
the ‘Vrije Universiteit He manages bitcointalk,
Reddit
in and Jeffrey
Amsterdam’. Telegram channelsmember
is an enthusiastic as well ascrypto
of the ICO community
communications. By background Jeffrey is
an IT
and engineer
is active andcrypto
on several works forforums.
related the ‘Vrije Universiteit
He has significant in Amsterdam’. Jeffrey is an enthusiastic
member ofof the
understanding crypto community
how cryptocurrencies andtheisimportance
work and also active on
of several crypto related forums. He
has significant
transparency understanding
and trust between the cryptoof how cryptocurrencies work and also the importance of
community.

transparency and trust between the crypto community.


Jeffrey Middelbos

16 | Farmatrust whitepaper v2.0 14/03/2018


FarmaTrust Advisors
FarmaTrust Advisors
FarmaTrust Advisors

David Allen Cohen


Chief Technology Advisor

Chief
David Technology
A. Cohen is
Chief Technology the Advisor
Chief
Advisor Technology Adviser at FarmaTrust. David is
internationally
David A. Cohen renowned for Technology
is the Chief his pioneering work in
Adviser at the Decentralized
FarmaTrust. David is
David
Software A. Cohen
industry,
internationally isfor
Digital
renowned the
Currency Chief Technology
and Blockchain
his pioneering industry.
work in the Adviser
David wasat FarmaTrust. David is internationally
Decentralized
renowned
named as one for
of the his
Top 100 pioneering
Movers and work
Shakers in in
the the
SmartGrid
Software industry, Digital Currency and Blockchain industry. David was
Decentralized
by Software industry, Digital
Currency
Greentech and
Media. Blockchain
HeTop
was100 the Movers industry.
founderand
andShakers David
CEO of Infotility was named
where heby as one of the Top 100 Movers and
named as one of the in the SmartGrid
Shakers
pioneered
in the SmartGrid by Greentech Media. He was the founder and CEO of Infotility
Greentech the “GridHe
Media. Edge”
was thecreating the and
founder industries
CEO offirst artificial
Infotility intelligence-
where he
where he pioneered the “Grid Edge” creating the industries first artificial intelligence-
based software
pioneered platform
the “Grid Edge” - GridAgents™. David is first
creating the industries a thought leader,
artificial intelligence-
based software platform - GridAgents™. David is a thought leader, speaking in venues
speaking in venues such-as MIT, TEDx, Consensus, Blockchain 100X and
David Allen Cohen
such as MIT, TEDx, Consensus, Blockchain 100X and Singularity University. He is an
based software platform GridAgents™. David is a thought leader,
Singularity University. He asis an expert onConsensus,
Blockchain, Blockchain
Artificial Intelligence,
expert
speaking inon Blockchain,
venues such MIT,Artificial
TEDx, Intelligence, Cybersecurity,
100X and and Edge Computing. He is a
David Allen Cohen
former
SingularityIOTA
Cybersecurity, and Foundation
Edge
University. Computing.
He is an expertmember.
He is a David
former
on Blockchain, IOTA is currently
Intelligence, founder and Chairman of dcntral, a
Foundation
Artificial
blockchain-based
member. Davidand
Cybersecurity, is currently Cybersecurity
founder and
Edge Computing. HeChairman company
is a formerofIOTA
dcntral, aas well as advisor on the Machine Economy
blockchain-
Foundation
for
basedHashgraph.
Cybersecurity company as well as advisor on the Machine
member. David is currently founder and Chairman of dcntral, a blockchain- Economy
for Hashgraph.
based Cybersecurity company as well as advisor on the Machine Economy
for Hashgraph.

Advisor
Peter MacLean is a successful entrepreneur with more than 45 years of
Peter
Advisor MacLean
experience in the IT industry and the profitable development of high
Advisor
Peter MacLean is a successful entrepreneur with more than 45 years of
growth technology businesses. Peter has many years board level
experience in the IT industry and the profitable development of high
experience as a chairman, chief executive and non-executive director of
Peter MacLean
growth technology is a successful
businesses. Peter has many entrepreneur
years board levelwith more than 45 years of experience in
private, venture capital / private equity backed and publicly quoted
the IT industry
experience andchief
as a chairman, theexecutive
profitable development
and non-executive ofofhigh growth technology businesses.
director
businesses and has also acted on the advisory boards of a number of
Peter has many
private, venture capital /years board
private equity leveland
backed experience
publicly quotedas a chairman, chief executive and non-
private equity funds. He has considerable experience of providing IT
executive
businesses and director of private,
has also acted venture
on the advisory capital
boards / private
of a number of equity backed and publicly quoted
services to enterprise and mid market companies, direct and channel
businesses and has also acted on the advisory boards of a number of private equity
private equity funds. He has considerable experience of providing IT
partner sales strategies, software design and development, the building
Peter MacLean funds.
services toHe has considerable
enterprise experience
and mid market companies, of channel
direct and providing IT services to enterprise and mid
and management of large scale data centres, including the provision of
market companies, direct and channel partner
partner sales strategies, software design and development, sales strategies, software design and
the building
Peter MacLean hosting and cloud based services, and of joint ventures and mergers and
development,
and management of the large building and
scale data centres, management of
including the provision
acquisitions having led more than 20 transactions across Europe,
large
of scale data centres, including the
provision of
hosting and cloud hosting and
based services,
Scandinavia, South Africa and Japan.
cloud
and based
of joint venturesservices,
and mergersand and of joint ventures and mergers and
acquisitions havinghaving
acquisitions led more led
than more
20 transactions
than 20 across Europe,
transactions across Europe, Scandinavia, South
Scandinavia,
Africa andSouth Africa and Japan.
Japan.

Advisor
Kate completed her pharmacy training with Pfizer, before commissioning
Advisor
into the British Army in 2006. Achieving the rank of Major, her diverse roles
Kate completed her pharmacy training with Pfizer, before commissioning
Kate
includedEnright
tours of Iraq, Afghanistan and British Forces Cyprus where, as
into the British Army in 2006. Achieving the rank of Major, her diverse roles
Advisor
Head of Medical Logistics, she led the pharmaceutical supply chain
included tours of Iraq, Afghanistan and British Forces Cyprus where, as
planning for the Volcanic Ash Cloud crisis.
Head of Medical Logistics, she led the pharmaceutical supply chain
Kate completed her pharmacy training with Pfizer, before commissioning into the British
planning for the Volcanic Ash Cloud crisis.
FarmaTrust whitepaper v2.0 Army in 2006. Achieving the rank of Major, 14/03/2018
her diverse roles included tours of Iraq,
FarmaTrust whitepaper v2.0 Afghanistan and British Forces Cyprus where,14/03/2018
as Head of Medical Logistics, she led the
pharmaceutical supply chain planning for the Volcanic Ash Cloud crisis.

Kate Enright

Advisor
Tim Ken Mackey is the Director of the Global Health Policy Institute, an
Associate Professor of Anesthesiology and Global Public Health at UC San
Diego School of Medicine, and is the Director for Healthcare Research &
Policy at UC San Diego Extension. He holds a BA in Political Science-
International Relations, a Masters Degree in Health Policy & Law and also
earned his PhD in Global Public Health from the joint doctoral program at
UC San Diego - San Diego State University.

Professor Timothy
Mackey
17 | Farmatrust whitepaper v2.0 14/03/2018
Kate Enright
Kate Enright

Advisor
Tim Ken Mackey is the Director of the Global Health Policy Institute, an
Advisor
Professor
Associate
Timothy
Professor
Mackeyand Global Public Health at UC San
of Anesthesiology
Tim Ken Mackey is the Director of the Global Health Policy Institute, an
Advisor
Diego School of Medicine, and is the Director for Healthcare Research &
Associate Professor of Anesthesiology and Global Public Health at UC San
Policy School
Diego at UC San Diego Extension.
of Medicine, HeDirector
and is the holds a for
BAHealthcare
in Political Research
Science- &
Tim Ken Mackey is
International
the DirectorinofHealth
the Global Health Policy Institute, an Associate Professor
Policy at UC Relations,
San Diego aExtension.
Masters Degree
He holds a BA inPolicy & Law
Political and also
Science-
of Anesthesiology
earned his PhD in Global
and Global
Public Health
Public
from
Health
the joint doctoral
at UC
program
San
at
Diego School of Medicine, and is
International Relations, a Masters Degree in Health Policy & Law and also
the
UC
Director
Sanhis
Diego
for Healthcare Research & Policy at UC San Diego Extension. He holds a BA
earned PhD- in
San Diego
Global StateHealth
Public University.
from the joint doctoral program at
in Political Science-International Relations, a Masters Degree in Health Policy & Law and
UC San Diego - San Diego State University.
also earned his PhD in Global Public Health from the joint doctoral program at UC San
Professor Timothy Diego - San Diego State University.
Mackey
Professor Timothy
Mackey

Chris
Advisor Saynor
Advisor
Chris pioneers innovative marketing strategies to reach the supply chain
Advisor
and logistics
Chris pioneersindustry. As the
innovative former strategies
marketing CEO of eyefortransport, Chris chain
to reach the supply
Chris
developed
and pioneers
logistics into theinnovative
eftindustry. world’s marketing
leadingCEO
As the former logistics strategies
business Chris to reach the supply chain and logistics
intelligence
of eyefortransport,
industry. As
company, organizing
developed the former
eft into theCEO-level CEO of
eventslogistics
world’s leading eyefortransport,
around business
the world intelligence
and specializingChris developed eft into the world’s
leading
company, logistics
in cutting edge
organizing business
supplyCEO-level
chain research. intelligence
eventsChris
around is now company,
a regular
the world and keynote organizing CEO-level events around
specializing
the world
speaker and and
event specializing
Chairman at Supplyin cutting
Chain edge
conferences
in cutting edge supply chain research. Chris is now a regular keynote supply
in both chain
Europe research. Chris is now a regular
keynote
and North speaker
America the and
world. event
Chris also Chairman
sits on the at Supply
Advisory
speaker and event Chairman at Supply Chain conferences in both Europe Board Chain
of conferences in both Europe and
North
Lanetix, America
a San the
Francisco world.
technology Chris
company also sits
that on
provides
and North America the world. Chris also sits on the Advisory Board of the Advisory
workflow and Board of Lanetix, a San Francisco
technology
collaboration company
solutions to the that provides
Logistics industry. workflow
He is also
Lanetix, a San Francisco technology company that provides workflow and an and
active collaboration solutions to the Logistics
Chris Saynor
industry.
Advisor to He
WTA, a is
104also
year an
old active
London Advisor
based to
Logistics WTA,
company.
collaboration solutions to the Logistics industry. He is also an active a 104 year old London based Logistics
Chris Saynor company.
Advisor to WTA, a 104 year old London based Logistics company.

Advisor
Stephen Cole is a well known international television news anchor for
Advisor
Stephen
Presidents,
almost three
Stephen ColeCole
Prime Ministers
decades.
is a well and
He has
known film stars.network
conducted
international He hosted and produced
interviews
television news with forthe
anchor
FarmaTrust whitepaper v2.0 Advisor
Oscars three
almost Special programme
decades. on conducted
He has BBC Worldnetwork
for six years. Stephen
interviews with
14/03/2018
successfully launched 4 of the world's main news channels, Sky News,
FarmaTrust whitepaper v2.0 14/03/2018
Stephen ColeMinisters
CNN International,
Presidents, Prime is World
BBC a and
well
and known
Al Jazeera international television
International. Stephen
film stars. He hosted and produced
is
the news anchor for almost three
decades.
also ChairmanHe andhas conducted
Moderator network
at World Economic interviews
Forum
Oscars Special programme on BBC World for six years. Stephen
at Davos,with Presidents, Prime Ministers and film

stars.
Eurasian HeMediahosted
Forum in and
successfully launched
Astanaproduced
and the Worldthe
4 of the world's Oscars
Science
main news channels,
Forum.Special
Stephen isprogramme on BBC World for six
Sky News,
years.
a judge atStephen successfully
the British Academy launched
of Film and 4
Television Arts,ofa the
Boardworld’s main news channels, Sky News,
CNN International, BBC World and Al Jazeera International. Stephen is
CNN
memberInternational, BBC
of the Global Thinkers
also Chairman and Moderator World
Forum
at World
andand AlForum
a former
Economic Jazeera
Director of International.
the world-
at Davos, Stephen is also Chairman and
famous Premiership
Moderator at LondonEconomic
World Welsh rugby club.
ForumHe isatcurrently
Davos, Chairman of
Eurasian Media Forum in Astana and the
Eurasian Media Forum in Astana and the World Science Forum. Stephen is
the Institute
World of Diplomacy
Science Forum.and Business.
Stephen is a judge at the British Academy of Film and Television
a judge at the British Academy of Film and Television Arts, a Board
Stephen Cole
Arts, a Board member of the Global Thinkers
member of the Global Thinkers Forum and a former Director of the world- Forum and a former Director of the world-
famous Premiership London Welsh rugby club.
famous Premiership London Welsh rugby club. He is currently Chairman of He is currently Chairman of the Institute of
Advisor
Diplomacy and Business.
the Institute of Diplomacy and Business.
Stephen Cole Desmond Marshall is the founder of Rouge Ventures, an investment and
strategic consulting firm in Asia, that serves numerous Fortune 500,
governments, traditional and new global companies. They conduct capital
Advisor
raising and advisory on investments, IPO/ICO/Blockchain projects, and
Desmond Marshall is the founder of Rouge Ventures, an investment and
other multi-industry businesses, for strategic repackaging and operational
Desmond Marshall
strategic consulting firm in Asia, that serves numerous Fortune 500,
enhancements. He serves on a number of ICO advisory boards.Mr
Advisor
governments, traditional and new global companies. They conduct capital
Marshall is one of the very first individuals in Asia to be a member of the
raising and advisory on investments, IPO/ICO/Blockchain projects, and
global Enterprise Ethereum Alliance, joining fellow ranks like Accenture, BP
Desmond Marshall
other multi-industry is for
businesses, thestrategic
founder of Rouge
repackaging Ventures, an investment and strategic
and operational
British Petroleum, Credit Suisse, JP Morgan, Microsoft, UBS, and many
consulting firm in Asia, that serves numerous
enhancements. He serves on a number of ICO advisory boards.Mr Fortune 500, governments, traditional and
other Fortune 500 companies. Mr Marshall has numerous experiences in
new global companies. They conduct capital raising
Marshall is one of the very first individuals in Asia to be a member of the and advisory on investments, IPO/
reviewing and vetting blockchain related investment projects since 2012
Desmond Marshall ICO/Blockchain projects,
global Enterprise Ethereum Alliance,and other
joining fellow multi-industry
ranks like Accenture,businesses,
BP for strategic repackaging
long before it became popular, and has an in-depth understanding of how
and
British operational
Petroleum, Creditenhancements. He serves
Suisse, JP Morgan, Microsoft, UBS, andonmany
a number of ICO advisory boards.Mr
investors and companies should operate under such a new trend.
Marshall
other Fortuneis500
one of the very
companies. first individuals
Mr Marshall has numerous in Asia to inbe a member of the global Enterprise
experiences
Ethereum
reviewing andAlliance, joining
vetting blockchain fellow
related ranksprojects
investment like Accenture,
since 2012 BP British Petroleum, Credit Suisse,
Desmond Marshall
JP
long Morgan, Microsoft,
before it became UBS,
popular, and and
has an many
in-depth other Fortune
understanding of how 500 companies. Mr Marshall has
numerous
investors
Advisor and experiences
companies should in reviewing
operate under and
such a newvetting
trend. blockchain related investment projects
since
Changki is one of the foremost blockchain evangelists in Korea. Not only an in-depth understanding of how
2012 long before it became popular, and has
investors
has he foundedandonecompanies should
of the earliest Korean operate under
cryptocurrencies, such
he is also a a new trend.
prominent blockchain speaker at congress-level conferences. Before
Advisor
founded Paxnet, Inc., one of the largest securities information portals in
Changki is one of the foremost blockchain evangelists in Korea. Not only
Korea
18 | Farmatrust whitepaper as
well as Finger, Inc., a major fintech company in Korea. Previously
hasv2.0
he founded one of the earliest Korean cryptocurrencies, he is also a 14/03/2018
he worked for Samsung for 14 years. He is the former head of the
prominent blockchain speaker at congress-level conferences. Before
Financial Engineering Research Center at the State University of New
founded Paxnet, Inc., one of the largest securities information portals in
Desmond Marshall
long before it became popular, and has an in-depth understanding of how
investors and companies should operate under such a new trend.

Changki
Advisor Park
Changki is one of the foremost blockchain evangelists in Korea. Not only
Advisor
has he founded one of the earliest Korean cryptocurrencies, he is also a
prominent blockchain
Changki is one of speaker at congress-level
the foremost conferences.
blockchain Before
evangelists in Korea. Not only has he founded
founded Paxnet, Inc., one of the largest securities information portals in
one of the earliest Korean cryptocurrencies, he is also a prominent blockchain speaker
Korea as well as Finger, Inc., a major fintech company in Korea. Previously
at congress-level conferences. Before founded Paxnet, Inc., one of the largest securities
he worked for Samsung for 14 years. He is the former head of the
information portals in Korea as well as Finger, Inc., a major fintech company in Korea.
Financial Engineering Research Center at the State University of New
Previously he worked for Samsung for 14 years. He is the former head of the Financial
York’s Korea campus.
Engineering Research Center at the State University of New York’s Korea campus.
Changki Park

Advisor
George
familiar withHan
George Han has extensive experience in the tech startup scene in
the startup investment scene and has helped created over 90
Advisor
Singapore, having run the incubator for a top Singapore university. He is
tech startups over 5 years.
FarmaTrust whitepaper v2.0 Presently he is a Managing Partner at SNAP Ventures, a Singapore-based
14/03/2018
George Han has
funds management extensive
firm that experience
invests in Blockchain, in theHealthcare
AI, Fintech, tech startup scene in Singapore, having
run the incubator for a top Singapore university.
and Cryptocurrencies. He takes a deep interest in Fintech companies and He is familiar with the startup
investment scene and has helped
selectively advises ICOs of promising tech businesses.created over 90 tech startups over 5 years.
Presently he isArtsafromManaging
George has a Bachelor Partner
Asia’s top university at University
- National SNAP Ventures, a Singapore-based
funds management
of Singapore and a MBA from the firmHull that invests
Business School in Blockchain, AI, Fintech, Healthcare and
Cryptocurrencies. He takes a deep interest in Fintech companies and selectively
advises ICOs of promising tech businesses.
George Han
George has a Bachelor Arts from Asia’s top university - National University of Singapore
and a MBA from the Hull Business School

FarmaTrust whitepaper v2.0 14/03/2018

19 | Farmatrust whitepaper v2.0 14/03/2018

You might also like